| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A7E2X7 | Topoisomerase (DNA) II binding protein 1; | TOPBP1; | NP_008958.2; | 1435 | human |
| A8K2H4 | cDNA FLJ78235; | NULL | NULL | 339 | human |
| A8K932 | cDNA FLJ76453, highly similar to Homo sapiens kinesin family member 9 (KIF9), transcript variant 2, mRNA; | NULL | NP_001128350.1;NP_071737.1;NP_878905.2; | 790 | human |
| A8KA29 | cDNA FLJ75302; | NULL | NULL | 690 | human |
| A7WPI9 | MHC class I antigen; Fragment; | HLA-A; | NULL | 273 | human |
| A8K4P7 | cDNA FLJ77493, highly similar to Homo sapiens G protein-coupled receptor 64 (GPR64), mRNA; | NULL | NP_005747.2; | 1014 | human |
| A8MZD0 | 15 kDa selenoprotein; | SEP15; | NULL | 144 | human |
| A8MWG7 | Mitogen-activated protein kinase kinase kinase 19; | MAP3K19; | NULL | 1152 | human |
| A8K6P0 | cDNA FLJ75039, highly similar to Homo sapiens aryl hydrocarbon receptor nuclear translocator (ARNT), transcript variant 3, mRNA; | NULL | NP_001184254.1; | 773 | human |
| A8MXP8 | Reticulocalbin-2; | RCN2; | NULL | 216 | human |
| A8K0Y1 | cDNA FLJ75576, highly similar to Homo sapiens brain-specific angiogenesis inhibitor 3 (BAI3), mRNA; | NULL | NULL | 1522 | human |
| A8KAQ8 | HERC2 protein; Fragment; | HERC2; | NP_004658.3; | 703 | human |
| E5RFK7 | E3 ubiquitin-protein ligase UBR5; Fragment; | UBR5; | NULL | 166 | human |
| J3QT41 | Tyrosine-protein phosphatase non-receptor type 4; Fragment; | PTPN4; | NULL | 197 | human |
| A8KAJ7 | Polypeptide N-acetylgalactosaminyltransferase; EC 2.4.1.-; Protein-UDP acetylgalactosaminyltransferase; | NULL | NULL | 559 | human |
| B0BCY8 | Glutamyl aminopeptidase; Aminopeptidase A; | ENPEP; | NULL | 957 | human |
| J3QTB2 | MICOS complex subunit MIC25; | CHCHD6; | NULL | 140 | human |
| B0BCY9 | Glutamyl aminopeptidase; Aminopeptidase A; | ENPEP; | NULL | 957 | human |
| A8MT02 | Small nuclear ribonucleoprotein-associated proteins B and B'; | SNRPB; | NULL | 288 | human |
| A8MX21 | Pre-B lymphocyte protein 3; | VPREB3; | NULL | 107 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |